Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
So MannKind just brought in Dominic Marasco as the new head of their endocrine business unit. Guy's got like 25+ years in biopharma, worked at Amgen, BioAgilytix, Envision Pharma – pretty solid resume for someone stepping into this role. Started back in January last year if I remember right.
The move seems pretty strategic honestly. They're betting on Afrezza gaining traction, and bringing in someone like Marasco with that kind of commercial background makes sense. He's supposed to help scale things up, especially with their inhaled delivery tech for diabetes and lung diseases.
That said, the insider trading activity is kinda interesting – been seeing mostly sells from their executives over the past few quarters. Marasco's got his work cut out for him. Worth watching how this plays out for $MNKD.